info icon

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

C3_MALE_GENITAL_NAS_WIDE

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

only males

226754

2. Check conditions

None

226754

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C63
  • Hospital discharge: ICD-9 187
  • Hospital discharge: ICD-8 187
  • Cause of death: ICD-10 C63
  • Cause of death: ICD-9 187
  • Cause of death: ICD-8 187
  • Cause of death: excluded ICD-9 187[1-4]
  • Cause of death: excluded ICD-8 1870
  • Cancer registry: Topography ICD-O-3 C63
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

63

4. Check minimum number of events

None

63

5. Include endpoints

None

63

6. Filter based on genotype QC (FinnGen only)

61

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 61 - 61
Unadjusted period prevalence (%) 0.03 - 0.03
Median age at first event (years) 65.24 - 65.24

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
63
Matched controls
630
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A98, ,
ICD-O-3
+∞
65.4
51
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
65.4
51
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
54.2
44
*
J01DB01, ,
ATC
cefalexin; oral
+∞
51.2
42
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
46.8
39
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
45.4
38
*
GD1AA, ,
ICD-O-3
+∞
45.4
38
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
44.0
37
*
J01DA01, ,
ATC
[U] cefalexin
+∞
42.6
36
*
S18, ,
ICD-O-3
+∞
38.5
33
*
WX110, ,
ICD-O-3
+∞
35.9
31
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
34.6
30
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
33.3
29
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
32.0
28
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
32.0
28
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
30.8
27
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
30.8
27
*
WX408, ,
ICD-O-3
+∞
29.5
26
*
I10, ,
ICD-O-3
+∞
28.2
25
*
SAA01, ,
ICD-O-3
+∞
28.2
25
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
28.2
25
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
28.2
25
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
28.2
25
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
28.2
25
*
ZXE10, ,
ICD-O-3
+∞
27.0
24
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
27.0
24
*
M03BX02, ,
ATC
tizanidine; oral
+∞
27.0
24
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
27.0
24
*
EB1AA, ,
ICD-O-3
+∞
27.0
24
*
C03CA01, ,
ATC
furosemide; systemic
+∞
25.8
23
*
ZXE00, ,
ICD-O-3
+∞
24.6
22
*
ZXD10, ,
ICD-O-3
+∞
24.6
22
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
24.6
22
*
N40, ,
ICD-10 Finland
Hyperplasia of prostate
+∞
24.6
22
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
24.6
22
*
UKC02, ,
ICD-O-3
+∞
23.4
21
*
Z024, ,
ICD-O-3
+∞
23.4
21
*
SPAT1153, ,
ICD-O-3
+∞
23.4
21
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
23.4
21
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
23.4
21
*
SPAT1250, ,
ICD-O-3
+∞
22.2
20
*
C08CA01, ,
ATC
amlodipine; oral
+∞
22.2
20
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
22.2
20
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
22.2
20
*
SPAT1256, ,
ICD-O-3
+∞
22.2
20
*
Z3231, ,
ICD-O-3
+∞
22.2
20
*
WZC00, ,
ICD-O-3
+∞
22.2
20
*
C10AA01, ,
ATC
simvastatin; oral
+∞
22.2
20
*
SPAT1263, ,
ICD-O-3
+∞
21.0
19
*
CJE20, ,
ICD-O-3
+∞
21.0
19
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
21.0
19
*
ZXD05, ,
ICD-O-3
+∞
21.0
19
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
21.0
19
*
SPAT1249, ,
ICD-O-3
+∞
19.8
18
*
K021, ,
ICD-O-3
+∞
19.8
18
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
19.8
18
*
SFA10, ,
ICD-O-3
+∞
19.8
18
*
C61, ,
ICD-10 Finland
Malignant neoplasm of prostate
+∞
19.8
18
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
19.8
18
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
19.8
18
*
WX320, ,
ICD-O-3
+∞
19.8
18
*
R4110, ,
ICD-O-3
+∞
19.8
18
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
18.6
17
*
D07AC01, ,
ATC
betamethasone; topical
+∞
18.6
17
*
SAA02, ,
ICD-O-3
+∞
18.6
17
*
KFC00, ,
ICD-O-3
+∞
18.6
17
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
18.6
17
*
XKD00, ,
ICD-O-3
+∞
18.6
17
*
SPAT1325, ,
ICD-O-3
+∞
18.6
17
*
EBA00, ,
ICD-O-3
+∞
18.6
17
*
WX402, ,
ICD-O-3
+∞
18.6
17
*
UJD10, ,
ICD-O-3
+∞
18.6
17
*
M796, ,
ICD-O-3
+∞
18.6
17
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
18.6
17
*
A10BA02, ,
ATC
metformin; oral
+∞
18.6
17
*
Z2221, ,
ICD-O-3
+∞
17.5
16
*
C619, 8140, 3
O3
+∞
17.5
16
*
AA1AD, ,
ICD-O-3
+∞
17.5
16
*
WYA05, ,
ICD-O-3
+∞
17.5
16
*
C09CA01, ,
ATC
losartan; oral
+∞
17.5
16
*
130, ,
Kela drug reimbursment
Malignant tumour
+∞
17.5
16
*
E0000UV, ,
ATC
+∞
17.5
16
*
TPH04, ,
ICD-O-3
+∞
17.5
16
*
SFA20, ,
ICD-O-3
+∞
17.5
16
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
17.5
16
*
B01AA03, ,
ATC
warfarin; systemic
+∞
17.5
16
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
16.3
15
*
R01AD09, ,
ATC
mometasone; nasal
+∞
16.3
15
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
16.3
15
*
I48, ,
ICD-10 Finland
Atrial fibrillation and flutter
+∞
16.3
15
*
ZXA05, ,
ICD-O-3
+∞
16.3
15
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
16.3
15
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
16.3
15
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
16.3
15
*
SPAT1310, ,
ICD-O-3
+∞
16.3
15
*
KC1EE, ,
ICD-O-3
+∞
16.3
15
*
R06AE07, ,
ATC
cetirizine; oral
+∞
16.3
15
*
WX002, ,
ICD-O-3
+∞
16.3
15
*
A06AD11, ,
ATC
lactulose; oral
+∞
16.3
15
*
C09AA02, ,
ATC
enalapril; systemic
+∞
15.2
14
*
SPAT1301, ,
ICD-O-3
+∞
15.2
14
*
FM1EE, ,
ICD-O-3
+∞
15.2
14
*
SPAT1262, ,
ICD-O-3
+∞
15.2
14
*
L17, ,
ICD-O-3
+∞
15.2
14
*
WX290, ,
ICD-O-3
+∞
15.2
14
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
15.2
14
*
SPAT1253, ,
ICD-O-3
+∞
15.2
14
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
15.2
14
*
SPAT1312, ,
ICD-O-3
+∞
15.2
14
*
N05CF01, ,
ATC
zopiclone; oral
+∞
15.2
14
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
14.1
13
*
WX700, ,
ICD-O-3
+∞
14.1
13
*
T90, ,
ICD-O-3
+∞
14.1
13
*
L28, ,
ICD-O-3
+∞
14.1
13
*
290, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
14.1
13
*
KMAK, ,
ICD-O-3
+∞
14.1
13
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
14.1
13
*
WZC30, ,
ICD-O-3
+∞
14.1
13
*
SFA30, ,
ICD-O-3
+∞
14.1
13
*
J069, ,
ICD-O-3
+∞
14.1
13
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
14.1
13
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
14.1
13
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
14.1
13
*
SAA03, ,
ICD-O-3
+∞
14.1
13
*
ZXA00, ,
ICD-O-3
+∞
14.1
13
*
GD1UA, ,
ICD-O-3
+∞
14.1
13
*
R05, ,
ICD-O-3
+∞
12.9
12
*
D01BA02, ,
ATC
terbinafine; oral
+∞
12.9
12
*
C07AB02, ,
ATC
metoprolol; systemic
+∞
12.9
12
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
12.9
12
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
12.9
12
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
12.9
12
*
C09AA05, ,
ATC
ramipril; oral
+∞
12.9
12
*
TPH07, ,
ICD-O-3
+∞
12.9
12
*
B01AB10, ,
ATC
tinzaparin; parenteral
+∞
12.9
12
*
SPAT1033, ,
ICD-O-3
+∞
12.9
12
*
T814, ,
ICD-10 Finland
Infection following a procedure, not elsewhere classified
+∞
12.9
12
*
SPAT1254, ,
ICD-O-3
+∞
12.9
12
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
12.9
12
*
XF400, ,
ICD-O-3
+∞
12.9
12
*
E000001, ,
ATC
+∞
11.8
11
*
D07AC13, ,
ATC
mometasone; topical
+∞
11.8
11
*
A28, ,
ICD-O-3
+∞
11.8
11
*
Z012, ,
ICD-O-3
+∞
11.8
11
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
11.8
11
*
SDA02, ,
ICD-O-3
+∞
11.8
11
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
11.8
11
*
JN4BD, ,
ICD-O-3
+∞
11.8
11
*
K045, ,
ICD-O-3
+∞
11.8
11
*
SCA01, ,
ICD-O-3
+∞
11.8
11
*
QBE10, ,
ICD-O-3
+∞
11.8
11
*
351, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
11.8
11
*
-1, ,
ICD-O-3
+∞
11.8
11
*
K409, ,
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
+∞
11.8
11
*
N06AB04, ,
ATC
citalopram; systemic
+∞
11.8
11
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
11.8
11
*
S21, ,
ICD-O-3
+∞
11.8
11
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
11.8
11
*
ZXE20, ,
ICD-O-3
+∞
11.8
11
*
JN3AE, ,
ICD-O-3
+∞
11.8
11
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
11.8
11
*
UJF32, ,
ICD-O-3
+∞
11.8
11
*
E7801, ,
ICD-10 Finland
Pure hypercholesterolaemia
+∞
11.8
11
*
SDA03, ,
ICD-O-3
+∞
11.8
11
*
M04AA01, ,
ATC
allopurinol; systemic
+∞
11.8
11
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
10.7
10
*
H02AB02, ,
ATC
dexamethasone; systemic
+∞
10.7
10
*
Z871, ,
ICD-O-3
+∞
10.7
10
*
Z718, ,
ICD-O-3
+∞
10.7
10
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
10.7
10
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
10.7
10
*
JAB30, ,
ICD-O-3
+∞
10.7
10
*
C632, ,
ICD-10 Finland
Malignant neoplasm: Scrotum
+∞
10.7
10
*
M480, ,
ICD-10 Finland
Spinal stenosis
+∞
10.7
10
*
SPAT1148, ,
ICD-O-3
+∞
10.7
10
*
I48, ,
ICD-O-3
+∞
10.7
10
*
KF8AE, ,
ICD-O-3
+∞
10.7
10
*
N03AX16, ,
ATC
[U] pregabalin
+∞
10.7
10
*
EB1HA, ,
ICD-O-3
+∞
10.7
10
*
K573, ,
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
+∞
10.7
10
*
I251, ,
ICD-10 Finland
Atherosclerotic heart disease
+∞
10.7
10
*
KED22, ,
ICD-O-3
+∞
10.7
10
*
Z515, ,
ICD-10 Finland
Palliative care
+∞
10.7
10
*
B01AF02, ,
ATC
apixaban; oral
+∞
10.7
10
*
116, ,
Kela drug reimbursment
Prostate cancer
+∞
10.7
10
*
SPAT1260, ,
ICD-O-3
+∞
10.7
10
*
C01DA08, ,
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
+∞
10.7
10
*
FN1AC, ,
ICD-O-3
+∞
10.7
10
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
10.7
10
*
GD1QA, ,
ICD-O-3
+∞
10.7
10
*
M02AA07, ,
ATC
piroxicam; topical
+∞
10.7
10
*
Z3226, ,
ICD-O-3
+∞
10.7
10
*
M161, ,
ICD-10 Finland
Other primary coxarthrosis
+∞
9.6
9
*
H02AB07, ,
ATC
prednisone; oral
+∞
9.6
9
*
C639, ,
ICD-10 Finland
Malignant neoplasm: Male genital organ, unspecified
+∞
9.6
9
*
R21, ,
ICD-O-3
+∞
9.6
9
*
E780, ,
ICD-O-3
+∞
9.6
9
*
R83, ,
ICD-O-3
+∞
9.6
9
*
206, ,
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
+∞
9.6
9
*
L03, ,
ICD-O-3
+∞
9.6
9
*
QBB10, ,
ICD-O-3
+∞
9.6
9
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
9.6
9
*
EB1SA, ,
ICD-O-3
+∞
9.6
9
*
N40, ,
ICD-O-3
+∞
9.6
9
*
C09CA06, ,
ATC
candesartan; oral
+∞
9.6
9
*
N390, ,
ICD-10 Finland
Urinary tract infection, site not specified
+∞
9.6
9
*
TPH15, ,
ICD-O-3
+∞
9.6
9
*
G04CB01, ,
ATC
finasteride; oral
+∞
9.6
9
*
E119, ,
ICD-O-3
+∞
9.6
9
*
S29, ,
ICD-O-3
+∞
9.6
9
*
SPAT1222, ,
ICD-O-3
+∞
9.6
9
*
G04CA52, ,
ATC
tamsulosin and dutasteride; systemic
+∞
9.6
9
*
C630, ,
ICD-10 Finland
Malignant neoplasm: Epididymis
+∞
9.6
9
*
L08, ,
ICD-O-3
+∞
9.6
9
*
SPAT1223, ,
ICD-O-3
+∞
9.6
9
*
R33, ,
ICD-10 Finland
Retention of urine
+∞
9.6
9
*
C01DA14, ,
ATC
isosorbide mononitrate; oral
+∞
9.6
9
*
JN4AD, ,
ICD-O-3
+∞
9.6
9
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
9.6
9
*
EBA05, ,
ICD-O-3
+∞
9.6
9
*
N10, ,
ICD-10 Finland
Acute tubulo-interstitial nephritis
+∞
9.6
9
*
PH2AE, ,
ICD-O-3
+∞
8.5
8
*
ZX120, ,
ICD-O-3
+∞
8.5
8
*
E11, ,
ICD-O-3
+∞
8.5
8
*
SPAT1053, ,
ICD-O-3
+∞
8.5
8
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
8.5
8
*
TKE00, ,
ICD-O-3
+∞
8.5
8
*
M01AC01, ,
ATC
piroxicam; systemic, rectal
+∞
8.5
8
*
A04AA01, ,
ATC
ondansetron; systemic, rectal
+∞
8.5
8
*
S04, ,
ICD-O-3
+∞
8.5
8
*
Z712, ,
ICD-O-3
+∞
8.5
8
*
M545, ,
ICD-O-3
+∞
8.5
8
*
QX3HE, ,
ICD-O-3
+∞
8.5
8
*
SPAT1230, ,
ICD-O-3
+∞
8.5
8
*
A97, ,
ICD-O-3
+∞
8.5
8
*
WX404, ,
ICD-O-3
+∞
8.5
8
*
A02BD03, ,
ATC
lansoprazole, amoxicillin and metronidazole; systemic
+∞
8.5
8
*
G04CB02, ,
ATC
dutasteride; oral
+∞
8.5
8
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
8.5
8
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
8.5
8
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
8.5
8
*
WX704, ,
ICD-O-3
+∞
8.5
8
*
D07AB08, ,
ATC
desonide; topical
+∞
8.5
8
*
WZB00, ,
ICD-O-3
+∞
8.5
8
*
KE1BE, ,
ICD-O-3
+∞
8.5
8
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
8.5
8
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
8.5
8
*
SPAT1149, ,
ICD-O-3
+∞
8.5
8
*
SPAT1043, ,
ICD-O-3
+∞
8.5
8
*
D82, ,
ICD-O-3
+∞
8.5
8
*
NA3AA, ,
ICD-O-3
+∞
8.5
8
*
R238, ,
ICD-O-3
+∞
8.5
8
*
H13, ,
ICD-O-3
+∞
8.5
8
*
NE1CG, ,
ICD-O-3
+∞
8.5
8
*
KE1AT, ,
ICD-O-3
+∞
8.5
8
*
R060, ,
ICD-O-3
+∞
8.5
8
*
C01DA02, ,
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
+∞
8.5
8
*
207, ,
Kela drug reimbursment
Chronic arrhythmias
+∞
8.5
8
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
8.5
8
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
8.5
8
*
M751, ,
ICD-O-3
+∞
8.5
8
*
SFA40, ,
ICD-O-3
+∞
7.4
7
*
SFC01, ,
ICD-O-3
+∞
7.4
7
*
I509, ,
ICD-10 Finland
Heart failure, unspecified
+∞
7.4
7
*
L01, ,
ICD-O-3
+∞
7.4
7
*
FM1AE, ,
ICD-O-3
+∞
7.4
7
*
D401, ,
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
+∞
7.4
7
*
R748, ,
ICD-10 Finland
Abnormal levels of other serum enzymes
+∞
7.4
7
*
J01DA06, ,
ATC
[U] cefuroxime
+∞
7.4
7
*
A29, ,
ICD-O-3
+∞
7.4
7
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
7.4
7
*
QAE10, ,
ICD-O-3
+∞
7.4
7
*
117, ,
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
7.4
7
*
K85, ,
ICD-O-3
+∞
7.4
7
*
H81, ,
ICD-O-3
+∞
7.4
7
*
N02AE01, ,
ATC
buprenorphine; parenteral, sublingual, transdermal
+∞
7.4
7
*
A03, ,
ICD-O-3
+∞
7.4
7
*
SPAT1255, ,
ICD-O-3
+∞
7.4
7
*
G04CA01, ,
ATC
alfuzosin; oral
+∞
7.4
7
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
7.4
7
*
L02AE02, ,
ATC
leuprorelin; implant, parenteral
+∞
7.4
7
*
NBG15, ,
ICD-O-3
+∞
7.4
7
*
SPAT1217, ,
ICD-O-3
+∞
7.4
7
*
L02BB03, ,
ATC
bicalutamide; oral
+∞
7.4
7
*
A46, ,
ICD-O-3
+∞
7.4
7
*
SPAT1292, ,
ICD-O-3
+∞
7.4
7
*
SDE03, ,
ICD-O-3
+∞
7.4
7
*
NBL00, ,
ICD-O-3
+∞
7.4
7
*
A04, ,
ICD-O-3
+∞
7.4
7
*
GD1PA, ,
ICD-O-3
+∞
7.4
7
*
NE1AA, ,
ICD-O-3
+∞
7.4
7
*
G03BA03, ,
ATC
testosterone; systemic, rectal, sublingual, transdermal
+∞
7.4
7
*
D649, ,
ICD-10 Finland
Anaemia, unspecified
+∞
7.4
7
*
M255, ,
ICD-O-3
+∞
7.4
7
*
R74, ,
ICD-O-3
+∞
7.4
7
*
R91, ,
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
+∞
7.4
7
*
R101, ,
ICD-10 Finland
Pain localized to upper abdomen
+∞
7.4
7
*
A499, ,
ICD-10 Finland
Bacterial infection, unspecified
+∞
7.4
7
*
Z760, ,
ICD-O-3
+∞
7.4
7
*
A10BH01, ,
ATC
sitagliptin; oral
+∞
7.4
7
*
D06AX01, ,
ATC
fusidic acid; topical
+∞
7.4
7
*
SPAT1306, ,
ICD-O-3
+∞
7.4
7
*
TKC20, ,
ICD-O-3
+∞
7.4
7
*
WX892, ,
ICD-O-3
+∞
7.4
7
*
SPAT1305, ,
ICD-O-3
+∞
6.3
6
*
ZXA10, ,
ICD-O-3
+∞
6.3
6
*
R31, ,
ICD-10 Finland
Unspecified haematuria
+∞
6.3
6
*
R53, ,
ICD-10 Finland
Malaise and fatigue
+∞
6.3
6
*
M01AH01, ,
ATC
celecoxib; oral
+∞
6.3
6
*
K0530, ,
ICD-O-3
+∞
6.3
6
*
N02AB03, ,
ATC
fentanyl; nasal, sublingual, transdermal
+∞
6.3
6
*
C01AA05, ,
ATC
digoxin; systemic
+∞
6.3
6
*
XF600, ,
ICD-O-3
+∞
6.3
6
*
B01AF01, ,
ATC
rivaroxaban; oral
+∞
6.3
6
*
J159, ,
ICD-10 Finland
Bacterial pneumonia, unspecified
+∞
6.3
6
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
6.3
6
*
N05CD07, ,
ATC
temazepam; oral
+∞
6.3
6
*
J189, ,
ICD-O-3
+∞
6.3
6
*
L82, ,
ICD-O-3
+∞
6.3
6
*
S460, ,
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
+∞
6.3
6
*
XF402, ,
ICD-O-3
+∞
6.3
6
*
K0364, ,
ICD-O-3
+∞
6.3
6
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
6.3
6
*
UJF30, ,
ICD-O-3
+∞
6.3
6
*
U05, ,
ICD-O-3
+∞
6.3
6
*
S97, ,
ICD-O-3
+∞
6.3
6
*
Y83, ,
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
6.3
6
*
UJF45, ,
ICD-O-3
+∞
6.3
6
*
WD105, ,
ICD-O-3
+∞
6.3
6
*
WX100, ,
ICD-O-3
+∞
6.3
6
*
TFP20, ,
ICD-O-3
+∞
6.3
6
*
K0365, ,
ICD-O-3
+∞
6.3
6
*
QDB10, ,
ICD-O-3
+∞
6.3
6
*
M171, ,
ICD-10 Finland
Other primary gonarthrosis
+∞
6.3
6
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
6.3
6
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
6.3
6
*
WD125, ,
ICD-O-3
+∞
6.3
6
*
VALMI, ,
ICD-O-3
+∞
6.3
6
*
114, ,
Kela drug reimbursment
Glaucoma
+∞
6.3
6
*
N05BA04, ,
ATC
oxazepam; oral
+∞
6.3
6
*
C61, ,
ICD-O-3
Prostate gland
+∞
6.3
6
*
C10AX09, ,
ATC
ezetimibe; oral
+∞
6.3
6
*
C03EA01, ,
ATC
hydrochlorothiazide and potassium-sparing agents; oral
+∞
6.3
6
*
M751, ,
ICD-10 Finland
Rotator cuff syndrome
+∞
6.3
6
*
XW000, ,
ICD-O-3
+∞
6.3
6
*
R238, ,
ICD-10 Finland
Other and unspecified skin changes
+∞
6.3
6
*
SPAT1304, ,
ICD-O-3
+∞
6.3
6
*
J01FA01, ,
ATC
erythromycin; systemic
+∞
6.3
6
*
L13, ,
ICD-O-3
+∞
6.3
6
*
I639, ,
ICD-10 Finland
Cerebral infarction, unspecified
+∞
6.3
6
*
JN3BD, ,
ICD-O-3
+∞
6.3
6
*
D07BC01, ,
ATC
betamethasone and antiseptics; topical
+∞
6.3
6
*
SPAT1156, ,
ICD-O-3
+∞
6.3
6
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
6.3
6
*
I702, ,
ICD-10 Finland
Atherosclerosis of arteries of extremities
+∞
6.3
6
*
A46, ,
ICD-10 Finland
Erysipelas
+∞
6.3
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
27
88
4.62
7.92
2.8
1.4
—
—
—
0
0
17
26
8.53
7.79
1.2
1.0
—
—
—
0
0
13
12
13.28
7.72
1.7
1.2
—
—
—
0
0
29
126
3.41
5.31
4.0
2.3
—
—
—
0
0
21
75
3.70
5.17
2.1
2.3
—
—
—
0
0
24
103
3.15
4.35
4.0
2.8
—
—
—
0
0
29
139
3.01
4.34
8.7
4.4
—
—
—
0
0
17
60
3.51
4.19
2.3
1.9
—
—
—
0
0
37
212
2.81
3.87
11.8
3.8
12.75
13.27
umol/l
0.11
37
200
10
21
5.45
3.74
27.2
35.0
—
—
—
0
0
9
18
5.64
3.52
3.3
1.7
—
—
—
0
0
22
101
2.81
3.44
9.6
4.6
—
—
—
0
0
24
116
2.73
3.41
5.0
2.5
0.96
0.41
e6/l
0.26
18
86
13
44
3.46
3.36
23.2
12.3
—
—
—
0
0
20
93
2.69
3.02
3.2
3.4
—
—
—
0
0
22
108
2.59
2.98
5.1
2.3
—
—
—
0
0
12
44
3.13
2.72
24.8
23.1
112.83
123.59
g/l
1.11
12
44
32
194
2.32
2.70
19.0
9.0
1.17
1.20
mmol/l
1.12
32
172
24
130
2.37
2.60
5.7
2.6
222.19
120.06
e6/l
0.20
18
101
14
58
2.82
2.59
2.6
1.6
1.74
1.49
%
0.79
14
47
14
58
2.82
2.59
21.9
18.3
0.39
1.33
mmol/l
0.37
14
46
37
242
2.28
2.57
25.5
18.8
1.58
1.41
inr
—
10
59
26
147
2.31
2.55
6.9
3.0
1427.83
21.30
e6/l
0.52
20
105
32
199
2.24
2.49
9.5
4.8
—
—
—
0
0
6
12
5.40
2.46
1.0
1.1
—
—
—
0
0
14
60
2.71
2.42
3.4
3.0
21.49
24.59
%
0.60
14
52
14
62
2.62
2.27
3.1
2.8
2.11
2.19
g/l
0.21
14
56
37
251
2.15
2.25
15.9
5.5
4.58
4.56
e9/l
0.01
32
219
39
280
2.03
1.93
12.3
6.5
6.92
6.97
mmol/l
0.05
39
264
9
36
2.74
1.82
1.6
1.3
57.97
65.26
g/l
—
9
28
32
219
1.94
1.77
9.2
4.8
0.63
0.63
e9/l
0.05
25
192
32
220
1.92
1.74
9.2
4.7
0.04
0.04
e9/l
0.20
24
194
32
222
1.90
1.68
10.0
5.0
2.60
1.79
e9/l
0.45
26
197
39
289
1.92
1.67
5.1
3.4
—
—
—
0
0
7
26
2.90
1.63
2.6
2.5
—
—
—
0
0
14
73
2.18
1.59
3.5
2.6
11.22
13.86
umol/l
1.09
14
64
13
66
2.22
1.57
23.3
9.0
103.38
104.79
mmol/l
0.41
13
66
28
190
1.85
1.54
16.7
8.0
0.00
0.00
e9/l
-0.00
20
153
32
228
1.82
1.50
11.3
4.9
0.19
0.21
e9/l
0.30
25
197
24
157
1.85
1.47
3.5
2.6
274.60
175.66
ug/l
0.38
24
143
5
16
3.30
1.46
19.0
3.1
—
—
—
0
0
43
337
1.87
1.46
13.4
5.2
80.49
73.75
u/l
0.78
43
310
5
17
3.10
1.38
2.4
1.5
22.80
20.88
s
—
5
17
5
17
3.10
1.38
1.0
1.2
—
—
—
0
0
9
43
2.27
1.37
1.4
2.0
—
—
—
0
0
16
96
1.89
1.25
6.9
3.5
48.31
150.50
ng/l
0.76
16
84
7
30
2.50
1.16
1.0
1.4
—
—
—
0
0
5
21
2.50
1.11
6.4
25.4
0.92
0.87
%
—
5
21
8
144
0.49
1.11
3.3
3.6
—
—
—
0
0
9
47
2.06
1.08
1.1
1.4
—
—
—
0
0
5
22
2.38
1.05
1.6
1.1
—
—
—
0
0
44
365
1.68
1.05
42.7
15.8
14.97
14.57
%
0.20
44
358
40
326
1.62
1.00
4.7
4.1
—
—
—
0
0
7
37
2.00
0.97
5.1
17.1
—
—
—
0
0
6
31
2.03
0.87
5.8
5.2
78.82
110.60
ng/l
—
6
25
0
26
0.00
0.80
0.0
3.7
—
4.45
—
0
18
17
118
1.60
0.80
2.7
1.8
3.10
2.75
mg/l
0.33
17
97
5
23
2.27
0.78
6.4
23.6
1.92
1.45
%
—
5
23
9
55
1.74
0.78
1.8
1.7
—
—
—
0
0
7
38
1.95
0.76
1.0
1.3
—
—
—
0
0
9
57
1.67
0.75
5.0
3.4
-2.13
1.55
mmol/l
—
9
43
9
57
1.67
0.75
5.0
3.4
5.63
5.84
kpa
—
9
52
7
40
1.84
0.74
1.6
1.3
—
—
—
0
0
7
42
1.75
0.71
1.6
1.5
—
—
—
0
0
14
96
1.59
0.69
1.1
1.2
—
—
—
0
0
5
28
1.85
0.67
1.2
1.3
—
—
—
0
0
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
8
59
1.41
0.43
3.9
3.3
5.01
8.31
ug/l
—
8
51
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
8
111
0.68
0.42
5.4
2.9
—
—
—
0
0
7
96
0.70
0.34
5.6
3.4
—
1.02
—
0
10
19
223
0.79
0.31
3.9
3.9
45.85
72.91
ng/l
0.67
13
172
41
441
0.80
0.30
5.5
5.4
2.34
2.49
mmol/l
0.59
41
401
21
182
1.23
0.26
2.8
2.5
1.27
0.81
ug/l
0.24
16
122
49
464
1.25
0.24
43.7
18.3
139.69
139.65
mmol/l
0.02
49
449
5
37
1.38
0.24
6.4
3.7
—
—
—
0
0
51
485
1.27
0.24
48.7
20.0
91.47
91.40
fl
0.04
51
473
13
107
1.27
0.24
2.2
1.8
553846488.54
390.59
pmol/l
0.47
13
85
8
103
0.74
0.23
2.9
1.9
1205.53
1258.13
nmol/l
—
8
79
49
465
1.24
0.23
44.7
18.3
4.00
4.04
mmol/l
0.42
49
449
51
486
1.26
0.23
48.7
19.9
30.24
30.61
pg
0.69
51
474
51
486
1.26
0.23
49.1
20.1
129.08
140.00
g/l
3.14
51
475
5
42
1.21
0.22
3.2
3.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
6
47
1.31
0.21
1.2
1.3
—
310.77
—
0
13
6
48
1.28
0.21
6.3
2.5
4.97
4.25
kpa
—
6
43
41
431
0.86
0.16
4.7
4.8
6.02
6.17
mmol/l
0.55
41
379
16
142
1.17
0.14
3.2
4.6
—
—
—
0
0
47
455
1.13
0.10
28.9
13.0
—
—
—
0
0
20
201
0.99
0.00
2.6
1.9
92.64
91.86
pmol/l
0.02
11
118
41
412
0.99
0.00
5.9
6.9
40.11
41.44
mmol/mol
0.51
41
378
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
332.80
—
0
5
0
9
0.00
-0.00
0.0
1.8
—
4.19
—
0
9
0
5
0.00
-0.00
0.0
4.6
—
0.10
—
0
5
0
8
0.00
-0.00
0.0
4.5
—
12.98
—
0
8
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
105.33
—
0
9
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
142.09
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.4
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: C3_MALE_GENITAL_NAS_WIDE – Malignant neoplasm of other and unspecified male genital organs, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).